Eton Pharmaceuticals, Inc. Share Price
ETONEton Pharmaceuticals, Inc. Stock Performance
Open $42.50 | Prev. Close $42.49 | Circuit Range N/A |
Day Range $40.24 - $42.50 | Year Range $13.85 - $42.52 | Volume 48,492 |
Average Traded $41.22 |
Eton Pharmaceuticals, Inc. Share Price Chart
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Eton Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $37.56 | $42.37 | +13.91% |
16-Jul-26 | $38.55 | $37.20 | -3.49% |
15-Jul-26 | $36.98 | $38.54 | +2.72% |
14-Jul-26 | $37.05 | $37.52 | +0.19% |
13-Jul-26 | $35.20 | $37.45 | +1.79% |
10-Jul-26 | $36.45 | $36.79 | -1.39% |
09-Jul-26 | $36.61 | $37.31 | +3.11% |